Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients
US11401344B2 · kind B2 · utility
0Cited by
4References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2018 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | Jan 12, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates generally to methods of accurately quantifying HER2 and/or p95 expression in subjects with a HER2 positive cancer and indicating the risk of brain relapse in such patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.